Instructors
Steve Jolley, MA
Chief Executive Officer, SJ Pharma Consulting, LLC, United States
Steve Jolley is a subject matter expert in all areas of global safety compliance and signal detection, and is a frequent speaker at leading industry events. Steve has 30 years’ experience in drug safety and pharmacovigilance and has worked with over 100 clients in North America, Europe, Japan, India and China. He holds degrees in mathematics and computer science from Cambridge University, England. He is an Adjunct Professor at Rutgers University and teaches part of their Master’s degree in Drug Safety and Pharmacovigilance.
Saad Shakir, DrMed, MD, FFPM, FISPE, FRCP
Cnsultant Pharmacovigilance and Pharmacoepidemiology , Consultant, United Kingdom
Saad Shakir is a pharmacoepidemiologist and drug safety physician. He has worked in the fields of pharmacovigilance, pharmacoepidemiology and risk management for 30 years, initially at the UK Regulatory Authority, then the international pharmaceutical industry and as the Director of the Drug Safety Research Unit (DSRU) in Southampton. He has led many important drug safety studies and has worked and advised on many drug safety issues including product withdrawals, major restrictions and important safety hazards. Saad will start a new stage in his career as a consultant in Pharmacovigilance and Pharmacoepidemiology on 1 June 2025